Efficacy of Pemetrexed-based Chemotherapy in Comparison to Non-Pemetrexed-based Chemotherapy in Advanced, ALK+ Non-Small Cell Lung Cancer.

MLA

Jo, Jaemin, et al. “Efficacy of Pemetrexed-Based Chemotherapy in Comparison to Non-Pemetrexed-Based Chemotherapy in Advanced, ALK+ Non-Small Cell Lung Cancer.” Yonsei Medical Journal, vol. 59, no. 2, Mar. 2018, pp. 202–10. EBSCOhost, https://doi.org/10.3349/ymj.2018.59.2.202.

APA

Jo, J., Kim, S. H., Kim, Y. J., Lee, J., Kim, M., Keam, B., Kim, T. M., Kim, D. W., Heo, D. S., Chung, J. H., Jeon, Y. K., & Lee, J. S. (2018). Efficacy of Pemetrexed-based Chemotherapy in Comparison to Non-Pemetrexed-based Chemotherapy in Advanced, ALK+ Non-Small Cell Lung Cancer. Yonsei Medical Journal, 59(2), 202–210. https://doi.org/10.3349/ymj.2018.59.2.202

Chicago

Jo, Jaemin, Se Hyun Kim, Yu Jung Kim, Juhyun Lee, Miso Kim, Bhumsuk Keam, Tae Min Kim, et al. 2018. “Efficacy of Pemetrexed-Based Chemotherapy in Comparison to Non-Pemetrexed-Based Chemotherapy in Advanced, ALK+ Non-Small Cell Lung Cancer.” Yonsei Medical Journal 59 (2): 202–10. doi:10.3349/ymj.2018.59.2.202.